CT引导下射频消融治疗von Hippel-Lindau病相关嗜铬细胞瘤的小样本病例系列:治疗安全性与结局
回顾性评估6例VHLD患者8个嗜铬细胞瘤经8次CT引导RFA的安全性与结局,7个一次完全消融,随访无局部进展或复发;5次消融出现血压升高(p=0.0078),高血压危象经静脉降压药控制良好,无肾上腺功能不全或其他重大并发症。
要点
- CT引导RFA治疗VHLD相关嗜铬细胞瘤可实现完全消融且保留肾上腺功能。
- 消融中血压升高常见(5/8次,p=0.0078),但高血压危象可经静脉药物控制。
- 所有消融均见瘤周少量出血,无需输血或干预。
核心结论
- CT引导RFA可安全治疗VHLD患者的嗜铬细胞瘤,高血压危象频繁但控制良好,可能获得良好肿瘤学结局并保留肾上腺功能。
研究设计与样本
- 回顾性病例系列,2012年9月至2025年2月间6例VHLD患者(男女比3:3,中位年龄30.5岁,范围19-48岁)的8个嗜铬细胞瘤(中位15.7 mm,范围5.5-22.5 mm)接受8次CT引导RFA。4例患者6个肿瘤曾行全或部分肾上腺切除术,2例患者2个肿瘤未行手术;无患者有高血压、心悸或出汗;2次消融前给予预用药。随访1-134个月(中位60.5个月),采用Wilcoxon配对符号秩检验。
诊断标准与关键数值
- 7/8个嗜铬细胞瘤一次消融完全,随访无局部肿瘤进展或复发。
- 1例使用低管电流(30 mAs)时残留肿瘤。
- 8次RFA中5次消融周期出现血压升高(p=0.0078)。
临床应用与阅片要点
- 消融过程中血压升高常见,需备好静脉降压药物处理高血压危象。
- 使用低管电流(30 mAs)时需注意可能残留肿瘤。
- 所有消融均见瘤周少量出血,通常无需输血或干预。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: We aimed to retrospectively assess the safety and outcomes of percutaneous radiofrequency ablation (RFA) of pheochromocytomas in patients with von Hippel-Lindau disease (VHLD).
MATERIALS AND METHODS: Between September 2012 and February 2025, eight pheochromocytomas (median, 15.7 mm; range, 5.5-22.5 mm) in six patients with VHLD (sex ratio = 3:3; median, 30.5 years; range, 19-48 years) were treated in eight computed tomography (CT)-guided RFA sessions. Four patients with six pheochromocytomas had undergone total or partial adrenalectomy, whereas two with two pheochromocytomas had not. No patients had pre-existing hypertension, palpitations, or sweating. Premedication was administered before the two sessions. Treatment outcomes, hypertensive crises, and other complications were assessed. Follow-up period ranged from 1 to 134 (median, 60.5) months. Wilcoxon matched-pairs signed-rank test was used for statistical analysis.
RESULTS: Of the eight pheochromocytomas, seven were completely ablated in one session, and no local tumor progression or recurrence was observed during follow-up. Only one patient had a residual tumor when a low tube current (30 mAs) was used. Of the eight RFA sessions, five resulted in elevated blood pressure during the RFA cycles (p = 0.0078). Hypertensive crises were managed well with intravenous antihypertensive medication without complications. No patient experienced adrenal insufficiency or other major complications. A small amount of bleeding was detected around the pheochromocytomas in all sessions but did not require transfusion or intervention.
CONCLUSION: CT-guided RFA can safely treat pheochromocytomas in patients with VHLD. Hypertensive crises are frequent but well controlled. It may achieve good oncological outcomes and preserve adrenal function.
引用
- Park BK. Computed tomography-guided radiofrequency ablation of pheochromocytomas in a small case series with von Hippel-Lindau disease: treatment safety and outcomes. Abdom Radiol (NY). 2025. PMID: 41134366. doi:10.1007/s00261-025-05258-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。